Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

Chalabi M, van den Dungen LDW, de Gooyer PGM, Balduzzi S, Aalbers AGJ, Kerver ED, Grootscholten C, Dokter S, Bloemen JG, Hendriks ER, Aukema TS, Oosterling SJ, Verbeek WHM, Voest EE, Kok NFM, Foppen MHG, Beets-Tan RG, Tin A, Jurdi A, Schumacher TN, van Leerdam ME, van den Berg JG, Haanen JBAG

Open source

DOI: 10.1016/s0140-6736(26)01602-8
Published: 2026 Oct 31
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01602-8,
  title = {Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.},
  author = {Chalabi M and van den Dungen LDW and de Gooyer PGM and Balduzzi S and Aalbers AGJ and Kerver ED and Grootscholten C and Dokter S and Bloemen JG and Hendriks ER and Aukema TS and Oosterling SJ and Verbeek WHM and Voest EE and Kok NFM and Foppen MHG and Beets-Tan RG and Tin A and Jurdi A and Schumacher TN and van Leerdam ME and van den Berg JG and Haanen JBAG},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(26)01602-8},
  url = {https://doi.org/10.1016/s0140-6736(26)01602-8}
}

RIS

TY  - JOUR
TI  - Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.
AU  - Chalabi M
AU  - van den Dungen LDW
AU  - de Gooyer PGM
AU  - Balduzzi S
AU  - Aalbers AGJ
AU  - Kerver ED
AU  - Grootscholten C
AU  - Dokter S
AU  - Bloemen JG
AU  - Hendriks ER
AU  - Aukema TS
AU  - Oosterling SJ
AU  - Verbeek WHM
AU  - Voest EE
AU  - Kok NFM
AU  - Foppen MHG
AU  - Beets-Tan RG
AU  - Tin A
AU  - Jurdi A
AU  - Schumacher TN
AU  - van Leerdam ME
AU  - van den Berg JG
AU  - Haanen JBAG
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01602-8
UR  - https://doi.org/10.1016/s0140-6736(26)01602-8
ER  -

APA

M, C., LDW, V. D. D., PGM, D. G., S, B., AGJ, A., ED, K., C, G., S, D., JG, B., ER, H., TS, A., SJ, O., WHM, V., EE, V., NFM, K., MHG, F., RG, B., A, T., A, J., TN, S., ME, V. L., JG, V. D. B., & JBAG, H. (2026). Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01602-8

Source records

pubmed · retrieved 2026-11-10T12:48:08.362Z